Autologous Stem Cell Therapy in Critical Limb Ischemia: A Meta-Analysis of Randomized Controlled Trials

<div>Forest plot of meta-analysis of the amputation rate in cell therapy and standard care for critical limb ischemia. (a) Subgroup analyses of bone marrow stem cells (BMSCs) versus peripheral blood stem cells (PBSCs). (b) Subgroup analyses of intramuscular (IM) versus intra-arterial (IA). Squares indicate the risk ratio, and horizontal lines represent 95% confidence intervals.</div>

Stem Cells International

fig2

Figure 2

Figure 2: Autologous Stem Cell Therapy in Critical Limb Ischemia: A Meta-Analysis of Randomized Controlled Trials 